PA8586601A1 - Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina - Google Patents

Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina

Info

Publication number
PA8586601A1
PA8586601A1 PA20038586601A PA8586601A PA8586601A1 PA 8586601 A1 PA8586601 A1 PA 8586601A1 PA 20038586601 A PA20038586601 A PA 20038586601A PA 8586601 A PA8586601 A PA 8586601A PA 8586601 A1 PA8586601 A1 PA 8586601A1
Authority
PA
Panama
Prior art keywords
organic
acid
isomero
benzhidril
bencilaminoquinuclidina
Prior art date
Application number
PA20038586601A
Other languages
English (en)
Spanish (es)
Inventor
Thomas C Nugent
Robert Seemayer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8586601A1 publication Critical patent/PA8586601A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PA20038586601A 2002-10-16 2003-10-16 Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina PA8586601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41905102P 2002-10-16 2002-10-16

Publications (1)

Publication Number Publication Date
PA8586601A1 true PA8586601A1 (es) 2005-02-04

Family

ID=32108014

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038586601A PA8586601A1 (es) 2002-10-16 2003-10-16 Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina

Country Status (21)

Country Link
US (2) US6861526B2 (https=)
EP (1) EP1551833A4 (https=)
JP (1) JP2006506368A (https=)
KR (1) KR100739901B1 (https=)
CN (1) CN100418964C (https=)
AP (1) AP2005003288A0 (https=)
AR (1) AR041587A1 (https=)
AU (1) AU2003277353B2 (https=)
BR (1) BR0315335A (https=)
CA (1) CA2500635A1 (https=)
EA (1) EA008192B1 (https=)
HR (1) HRP20050328A2 (https=)
IS (1) IS7755A (https=)
MX (1) MXPA05004058A (https=)
PA (1) PA8586601A1 (https=)
PE (1) PE20040777A1 (https=)
PL (1) PL376218A1 (https=)
TN (1) TNSN05111A1 (https=)
UY (1) UY28024A1 (https=)
WO (1) WO2004035575A1 (https=)
ZA (1) ZA200502411B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
LT1713504T (lt) * 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
SI1713801T1 (sl) * 2004-02-02 2008-04-30 Pfizer Prod Inc Postopek priprave 1-(2S,3S)-2-benzhidril-N-(5-terc-butil-2-metoksibenzil)kinuklidin-3- amina
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
KR101452915B1 (ko) 2006-05-04 2014-10-21 베링거 인겔하임 인터내셔날 게엠베하 다형태
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CA3070513C (en) 2010-05-05 2023-01-03 Boehringer Ingelheim International Gmbh A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
KR20130093012A (ko) 2010-06-24 2013-08-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013171166A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法
CN108341811A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 马罗皮坦杂质的制备方法
CN106977512B (zh) * 2017-05-04 2019-01-01 海门慧聚药业有限公司 制备马罗匹坦游离碱的方法
WO2025172911A1 (en) * 2024-02-16 2025-08-21 Teadus Pharmaceuticals Pvt. Ltd A process for the preparation of (2s,3s)-2-benzhydryl- n-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine and pharmaceutically acceptable salts thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560510A (en) * 1969-03-05 1971-02-02 Aldrich Chem Co Inc 2-benzhydrylquinuclidines
US4680283A (en) 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
US5138060A (en) 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
UA26401C2 (uk) * 1991-05-22 1999-08-30 Пфайзер Інк. Заміщеhі 3-аміhохіhуклідиhи
AU657552B2 (en) 1991-05-31 1995-03-16 Pfizer Inc. Quinuclidine as substance P antagonists
WO1994004496A1 (en) 1992-08-19 1994-03-03 Pfizer Inc. Substituted benzylamino nitrogen containing non-aromatic heterocycles
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists
JP2656699B2 (ja) 1992-10-21 1997-09-24 ファイザー製薬株式会社 置換ベンジルアミノキヌクリジン
JP2656700B2 (ja) 1992-10-28 1997-09-24 ファイザー製薬株式会社 置換キヌクリジン誘導体
CA2149242C (en) * 1992-11-12 1998-08-04 Fumitaka Ito Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders
IL109646A0 (en) 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
PE8798A1 (es) * 1995-07-17 1998-03-02 Pfizer Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
MX9706944A (es) 1996-09-12 1998-08-30 Pfizer Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p.

Also Published As

Publication number Publication date
US20050085641A1 (en) 2005-04-21
UY28024A1 (es) 2004-05-31
US20040116704A1 (en) 2004-06-17
BR0315335A (pt) 2005-08-16
AU2003277353B2 (en) 2007-08-09
AR041587A1 (es) 2005-05-26
EA200500650A1 (ru) 2005-10-27
US6861526B2 (en) 2005-03-01
MXPA05004058A (es) 2005-06-08
AU2003277353A1 (en) 2004-05-04
ZA200502411B (en) 2006-05-31
CN100418964C (zh) 2008-09-17
IS7755A (is) 2005-03-17
WO2004035575A8 (en) 2005-05-12
EP1551833A1 (en) 2005-07-13
HK1078087A1 (en) 2006-03-03
JP2006506368A (ja) 2006-02-23
HRP20050328A2 (en) 2005-06-30
TNSN05111A1 (en) 2007-05-14
PL376218A1 (en) 2005-12-27
CN1705664A (zh) 2005-12-07
KR20050083764A (ko) 2005-08-26
AP2005003288A0 (en) 2005-06-30
KR100739901B1 (ko) 2007-07-13
EP1551833A4 (en) 2010-06-02
WO2004035575A1 (en) 2004-04-29
PE20040777A1 (es) 2004-11-20
EA008192B1 (ru) 2007-04-27
CA2500635A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
PA8586601A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina
Liu et al. Trifluoromethylfluorosulfonylation of Unactivated Alkenes Using Readily Available Ag (O2CCF2SO2F) and N‐Fluorobenzenesulfonimide
CO6140053A2 (es) Proceso para fabricar 2-amino-5-halobenzamidas 3-sustituidas
EA201390415A1 (ru) Состав для цементирования ствола скважины и способ его приготовления и использования
CO5630034A1 (es) Metodo para producir esteres de alquilo
PE20021014A1 (es) Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad
Tang et al. Hexafluoro‐2‐propanol Promotes para‐Selective C–H Amination of Free Anilines with Azodicarboxylates
Xue et al. Highly regio-and stereoselective nitro-oxoamination of mono-substituted allenes
Monleón et al. Organocatalytic Strategy for the Enantioselective Cycloaddition to Trisubstituted Nitroolefins to Create Spirocyclohexene‐Oxetane Scaffolds
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
BRPI0411195A (pt) método para a preparação de uma oxazinona fundida e método para a preparação de um composto
PA8594901A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina
AR057022A1 (es) Proceso para resolver un r o s acido mandelico a partir de su mezcla racemica
TW200724495A (en) Nanowires and a method of the same
Kargbo et al. Synthesis of 3-benzazepines and azepino [4, 5-b] heterocyclic ring systems via intramolecular Friedel–Crafts cyclization
AR070754A1 (es) Proceso mejorado para preparar clorhidrato de cinacalcet
EA200201233A1 (ru) Способ получения бифенильных соединений
CN103554126A (zh) 油田用示踪剂的荧光素衍生物制备方法与应用
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
CN103087033A (zh) 一种多取代氧杂环庚三烯-3(2h)-酮类化合物的合成方法
CN103333078B (zh) 一种阿那格雷关键中间体、类似物或其盐的合成方法
Quek et al. New highly efficient method for the synthesis of tert-alkyl nitroso compounds
MD4443B1 (ro) Procedeu de sinteză a 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carbonitrilului şi aplicarea lui în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid acceptabil farmaceutic
EA200800861A1 (ru) Способ получения четвертичных аммониевых солей с кислотой
RU2010120060A (ru) Способ получения 3-замещенных 1,2-бензизоксазол-5,6-дикарбонитрилов